How the cell nucleus controls genes and disease

Molecular mechanisms in the mammalian cell nucleus

NIH-funded research Rice University · NIH-11121055

Researchers are building ultra-precise imaging tools to watch individual molecules and DNA inside living cells to learn how changes in the cell nucleus relate to cancer and other diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRice University NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11121055 on NIH RePORTER

What this research studies

This team will create and combine advanced single-molecule and super-resolution microscopes with 3D optics and light-sheet illumination to image molecules in living cells with very high spatial and time resolution. They will use special labeling methods, including dCas9-linked tags, to track chromatin (DNA and its proteins) over time and in three dimensions. The group will pair imaging with microfluidic control of the cell environment to see how nuclear structure and dynamics respond to changes that relate to cancers and inherited nuclear-envelope disorders. The work focuses on basic cellular mechanisms rather than testing a treatment, with the aim of revealing how nuclear organization affects gene activity during disease.

Who could benefit from this research

Good fit: People with cancers or inherited nuclear-envelope conditions (for example laminopathies or ciliopathies) would be the most relevant patient groups to connect with this research.

Not a fit: People seeking an immediate treatment benefit or those without diseases linked to nuclear or chromatin dysfunction are unlikely to directly benefit from this basic laboratory research.

Why it matters

Potential benefit: If successful, this work could reveal new markers or molecular steps in cancer and related diseases that lead to better diagnostics or drug targets in the future.

How similar studies have performed: Related labs have successfully used single-molecule imaging and CRISPR/dCas9 labeling to map chromatin behavior, but translating those findings into clinical tests or therapies is still early-stage.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.